Abstract
Background and objectivesInterleukin 6 (IL-6) is a key inflammatory cytokine in the pathobiology of rheumatoid arthritis (RA) and biological therapies targeting the IL-6 receptor have shown clinical benefit. The production...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have